Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SVF Enriched PRP vs PRP or SVF for Atrophic Post-acne Scars
NCT06524011Not yet recruiting
- Sponsor
- Zagazig University
- Start
- Dec 2024
- Primary completion
- Dec 2025
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
Randomised, open-label trial of autologous adipose stromal vascular fraction and platelet-rich plasma in atrophic acne scar (3 arms), sponsored by Zagazig University. Primary endpoint: Change in severity of acne scars using Goodman scoring system. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
autologous adipose stromal vascular fractionplatelet-rich plasma
03
Conditions
atrophic acne scar
Beyond the preview
Go deeper on NCT06524011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06524011.